Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 08-2024 | 05-2024 | 02-2024 | 11-2023 | 08-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,520 | 8,462 | 3,073 | 3,221 | 8,642 |
| Receivables | 25,145 | 27,084 | 31,445 | 30,202 | 26,617 |
| Inventories | 41,642 | 39,979 | 39,670 | 41,446 | 41,690 |
| Other current assets | 0 | 4,069 | 0 | 0 | 0 |
| TOTAL | $74,183 | $81,033 | $76,157 | $76,714 | $82,814 |
| Non-Current Assets | |||||
| PPE Net | 148,756 | 149,165 | 145,367 | 142,913 | 136,259 |
| Intangibles | 18,081 | 18,081 | 18,081 | 18,081 | 18,081 |
| Other Non-Current Assets | 5,804 | 5,681 | 6,636 | 8,108 | 8,466 |
| TOTAL | $172,641 | $172,927 | $170,084 | $169,102 | $162,806 |
| Total Assets | $246,824 | $253,960 | $246,241 | $245,816 | $245,620 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 773 | N/A | 773 | 773 | 773 |
| Accounts payable and accrued liabilities | 18,010 | 16,334 | 15,685 | 19,023 | 15,691 |
| Accrued Expenses | 5,565 | 18,575 | 4,070 | 3,354 | 4,516 |
| TOTAL | $40,523 | $38,872 | $36,810 | $40,254 | $35,414 |
| Non-Current Liabilities | |||||
| Long Term Debt | 151,650 | 149,125 | 139,249 | 152,963 | 171,847 |
| Deferred Revenues | 654 | N/A | 3,231 | 8,254 | 8,357 |
| Other Non-Current Liabilities | 5,114 | 12,061 | 10,141 | 9,517 | 9,662 |
| TOTAL | $166,798 | $161,186 | $149,997 | $163,217 | $183,652 |
| Total Liabilities | $207,321 | $200,058 | $186,807 | $203,471 | $219,066 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,898 | N/A | 30,870 | 30,870 | 30,870 |
| Common Shares | 31 | 31 | 30 | 30 | 30 |
| Retained earnings | -182,753 | -166,523 | -159,440 | -175,072 | -189,290 |
| Other shareholders' equity | 43,441 | 42,587 | 41,748 | 40,924 | 40,114 |
| TOTAL | $39,503 | $53,902 | $59,434 | $42,345 | $26,554 |
| Total Liabilities And Equity | $246,824 | $253,960 | $246,241 | $245,816 | $245,620 |